Literature DB >> 25109840

Developmental pathways activated in melanocytes and melanoma.

Jianglan Liu1, Mizuho Fukunaga-Kalabis1, Ling Li1, Meenhard Herlyn2.   

Abstract

Cutaneous malignant melanomas originate primarily within epidermal melanocytic cells. Melanoma cells share many characteristics with melanocyte precursors, suggesting that melanoma cells utilize the developmental programs of their normal counterpart for their own progression. The pigmentation system provides an advantageous model to assess survival pathway interactions in the melanocytic lineage, as genetic alterations controlling melanocyte development can be easily detectable by coat color phenotype that do not affect the viability of an animal. By integrating combinatorial gene knockout approaches, cell-based assays and immunohistochemical observations, recent studies have illustrated several genes and pathways that play important roles both in melanocyte specification and maintenance and in melanoma formation and progression. We are reviewing those genes and pathways to understand the connection between normal and cancerous development and to reveal therapeutic potential of targeting developmental pathways for melanoma therapy.

Entities:  

Keywords:  Beta-catenin; Endothelin; MITF; Melanocytes; Melanoma; Notch; Signaling pathways; Sox10; Sox9; Wnt

Mesh:

Substances:

Year:  2014        PMID: 25109840      PMCID: PMC4221383          DOI: 10.1016/j.abb.2014.07.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  84 in total

Review 1.  Having it both ways: Sox protein function between conservation and innovation.

Authors:  S I E Guth; M Wegner
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

2.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

3.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

4.  Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.

Authors:  Travis L Biechele; Rima M Kulikauskas; Rachel A Toroni; Olivia M Lucero; Reyna D Swift; Richard G James; Nick C Robin; David W Dawson; Randall T Moon; Andy J Chien
Journal:  Sci Signal       Date:  2012-01-10       Impact factor: 8.192

5.  Notch signaling promotes growth and invasion in uveal melanoma.

Authors:  Laura Asnaghi; Katayoon B Ebrahimi; Karisa C Schreck; Eli E Bar; Michael L Coonfield; W Robert Bell; James Handa; Shannath L Merbs; J William Harbour; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

Review 6.  A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis.

Authors:  Marie R Webster; Ashani T Weeraratna
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

7.  Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Authors:  Gunhild M Maelandsmo; Ruth Holm; Jahn M Nesland; Øystein Fodstad; Vivi Ann Flørenes
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

Review 8.  Dynamics of cell interactions and communications during melanoma development.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Crit Rev Oral Biol Med       Date:  2002

9.  Active Notch1 confers a transformed phenotype to primary human melanocytes.

Authors:  Chelsea C Pinnix; John T Lee; Zhao-Jun Liu; Ronan McDaid; Klara Balint; Levi J Beverly; Patricia A Brafford; Min Xiao; Benjamin Himes; Susan E Zabierowski; Yumi Yashiro-Ohtani; Katherine L Nathanson; Ana Bengston; Pamela M Pollock; Ashani T Weeraratna; Brian J Nickoloff; Warren S Pear; Anthony J Capobianco; Meenhard Herlyn
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

10.  Lineage-specific requirements of beta-catenin in neural crest development.

Authors:  Lisette Hari; Véronique Brault; Maurice Kléber; Hye-Youn Lee; Fabian Ille; Rainer Leimeroth; Christian Paratore; Ueli Suter; Rolf Kemler; Lukas Sommer
Journal:  J Cell Biol       Date:  2002-12-09       Impact factor: 10.539

View more
  30 in total

Review 1.  Unlocking the Complexities of Tumor-Associated Regulatory T Cells.

Authors:  Jaime L Chao; Peter A Savage
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

3.  Cyclin-dependent kinase 5 regulates proliferation, migration, tyrosinase activity, and melanin production in B16-F10 melanoma cells via the essential regulator p-CREB.

Authors:  Xiuqing Li; Ruifang Wang; Junzhen Zhang; Shanshan Yang; Kaiyuan Ji; Bin Du; Xuexian Liu; Bo Liu; Shuhui Qi; Qiong Jia; Ruiwen Fan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-05-08       Impact factor: 2.416

Review 4.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

5.  The DNA methylation landscape of human melanoma.

Authors:  Seung-Gi Jin; Wenying Xiong; Xiwei Wu; Lu Yang; Gerd P Pfeifer
Journal:  Genomics       Date:  2015-09-15       Impact factor: 5.736

6.  Cleistanthin A inhibits the invasion and metastasis of human melanoma cells by inhibiting the expression of matrix metallopeptidase-2 and -9.

Authors:  Sheng Pan; Hengji Cai; Lixiong Gu; Shuanglin Cao
Journal:  Oncol Lett       Date:  2017-09-08       Impact factor: 2.967

7.  A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.

Authors:  Daniel Ortega-Bernal; Claudia H González-De La Rosa; Elena Arechaga-Ocampo; Miguel Angel Alvarez-Avitia; Nora Sobrevilla Moreno; Claudia Rangel-Escareño
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

8.  miFAST: A novel and rapid microRNA target capture method.

Authors:  Ashley M Poenitzsch Strong; Scott M Berry; David J Beebe; Jian-Liang Li; Vladimir S Spiegelman
Journal:  Mol Carcinog       Date:  2018-02-12       Impact factor: 4.784

Review 9.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

10.  Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.

Authors:  Helena Cirenajwis; Henrik Ekedahl; Martin Lauss; Katja Harbst; Ana Carneiro; Jens Enoksson; Frida Rosengren; Linda Werner-Hartman; Therese Törngren; Anders Kvist; Erik Fredlund; Pär-Ola Bendahl; Karin Jirström; Lotta Lundgren; Jillian Howlin; Åke Borg; Sofia K Gruvberger-Saal; Lao H Saal; Kari Nielsen; Markus Ringnér; Hensin Tsao; Håkan Olsson; Christian Ingvar; Johan Staaf; Göran Jönsson
Journal:  Oncotarget       Date:  2015-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.